JPRN-UMIN000011745已完成未知
Prospective, randomized, open-label, clinical trial comparing rosuvastatin monotherapy and combination therapy with ezetimibe on progression of atherosclerotic plaques and endothelial function - Clinical trial comparing rosuvastatin monotherapy and combination therapy with ezetimibe
ational Defense Medical College0 个研究点目标入组 66 人开始时间: 2013年9月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy against rosuvastatin or ezetimibe 2) Poor-controlled diabetes (HbA1c>10.0 %) 3) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 4) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 5) End stage renal disease 6) Symptomatic (NYHA III or IV) congestive heart failure 7) Malignancies or other diseases with poor prognosis 8) Pregnant 9) Subjects whose doctor in charge do not agree to join the trial
研究者
相似试验
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of ariskiren and amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000004539ational Defense Medical College60
已完成
4 期
Prospective, randomized, open-label, clinical trial comparing fibrate monotherapy and fibrate-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative propertiesdyslipidemiaJPRN-UMIN000002964ational Defense Medical College60
招募中
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of hydrogen tablet and placebo on blood pressure, endothelial function and makers for cardiovascular diseasesHypertensionJPRN-UMIN000021154Tokorozawa Heart Center34
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of statin monotherapy and statin-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, markers for anti-inflammatory properties/obesity/antioxidative propertiesCoronary artery diseasesJPRN-UMIN000002960ational Defense Medical College60
招募中
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of topiroxostat and febuxostat on serum uric acid, endothelial function and markers for kidney injuryJPRN-UMIN000026765Tokorozawa Heart Center33